“…Human pheochromocytoma was the first tumor in which galanin was identified (Bauer et al, 1986c;Hacker et al, 1988), and later galanin-like immunoreactivity was detected in other neuroendocrine tumors, including human pituitary adenoma (Bauer et al, 1986c;Hacker et al, 1988). Subsequently, galanin-like immunoreactivity was detected in human pituitary adenoma particularly associated with adrenocorticotrophic hormone-secreting cells (Hulting et al, 1989;Vrontakis et al, 1990;Bennet et al, 1991;Hsu et al, 1991;Sano et al, 1991;Leung et al, 2002;Grenback et al, 2004) and in gangliocytoma (Sano et al, 1991;Felix et al, 1994), paraganglioma (Fried et al, 1994;Tadros et al, 2003), and neuroblastoma (Tuechler et al, 1998). Alarin was subsequently detected in differentiated neuroblastoma cells (Santic Galanin Family Peptides and Receptors et al, 2006) and was recently detected in a variety of human CNS tumors and suggested to be a diagnostic marker for ependymoma to differentiate them from other gliomas (Eberhard et al, 2013).…”